Susanne Johansson

1.5k total citations
53 papers, 1.1k citations indexed

About

Susanne Johansson is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Susanne Johansson has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 11 papers in Nephrology. Recurrent topics in Susanne Johansson's work include Atrial Fibrillation Management and Outcomes (9 papers), Ion Transport and Channel Regulation (7 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). Susanne Johansson is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Ion Transport and Channel Regulation (7 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). Susanne Johansson collaborates with scholars based in Sweden, United States and United Kingdom. Susanne Johansson's co-authors include Anders Lindberg, Mikael Knutsson, David P. Rosenbaum, Ulf G. Eriksson, Maria Leonsson‐Zachrisson, S. Henriksson, Ragnar Asplund, Göran Isacsson, Bo Niklasson and Lars Frison and has published in prestigious journals such as The Journal of Physical Chemistry B, The Journal of Clinical Endocrinology & Metabolism and Journal of Virology.

In The Last Decade

Susanne Johansson

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Johansson Sweden 21 311 212 204 177 158 53 1.1k
Nam Ho Kim South Korea 21 252 0.8× 213 1.0× 234 1.1× 374 2.1× 88 0.6× 125 1.4k
Gabriele Halwachs‐Baumann Austria 20 218 0.7× 143 0.7× 45 0.2× 150 0.8× 167 1.1× 51 1.4k
İbrahim Aydın Türkiye 18 111 0.4× 290 1.4× 49 0.2× 195 1.1× 51 0.3× 81 1.0k
Ellis Jacobs United States 14 237 0.8× 239 1.1× 91 0.4× 90 0.5× 22 0.1× 36 896
Lei Hou China 17 207 0.7× 131 0.6× 38 0.2× 149 0.8× 47 0.3× 51 793
William D. Hoffman United States 22 478 1.5× 420 2.0× 127 0.6× 280 1.6× 44 0.3× 51 1.8k
Hua Ling United States 19 279 0.9× 152 0.7× 32 0.2× 176 1.0× 181 1.1× 65 1.0k
Eizo Watanabe Japan 25 114 0.4× 291 1.4× 324 1.6× 419 2.4× 184 1.2× 63 2.1k
Céline Lange France 15 227 0.7× 113 0.5× 147 0.7× 436 2.5× 75 0.5× 33 1.3k
Yu Cao China 20 195 0.6× 248 1.2× 28 0.1× 254 1.4× 190 1.2× 89 1.1k

Countries citing papers authored by Susanne Johansson

Since Specialization
Citations

This map shows the geographic impact of Susanne Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Johansson more than expected).

Fields of papers citing papers by Susanne Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Johansson. The network helps show where Susanne Johansson may publish in the future.

Co-authorship network of co-authors of Susanne Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Johansson. A scholar is included among the top collaborators of Susanne Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Johansson. Susanne Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xueqing, Maria Heijer, Ryan A. Bragg, et al.. (2023). Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects. Drug Metabolism and Disposition. 51(8). 995–1004. 7 indexed citations
3.
Johansson, Susanne, David Han, Thomas R. Hunt, et al.. (2022). Pharmacokinetics, pharmacodynamics, and safety of verinurad with and without allopurinol in healthy Asian, Chinese, and non‐Asian participants. Pharmacology Research & Perspectives. 10(3). e00929–e00929. 5 indexed citations
4.
Vildhede, Anna, Tommy B. Andersson, Fredrik Erlandsson, et al.. (2021). In Vitro Assessment of the Drug–Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters. Journal of Pharmacology and Experimental Therapeutics. 378(2). 108–123. 3 indexed citations
5.
Larsson, Andreas, Johanna Qvarnström, Elisabeth Wigenstam, et al.. (2020). In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX. Toxicology Letters. 339. 32–38. 11 indexed citations
6.
Stack, Austin G., Nalina Dronamraju, Joanna Parkinson, et al.. (2020). Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial. American Journal of Kidney Diseases. 77(4). 481–489. 54 indexed citations
7.
Johansson, Susanne, et al.. (2017). Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions. Clinical Pharmacology in Drug Development. 6(5). 466–475. 10 indexed citations
8.
Johansson, Susanne, David P. Rosenbaum, Johan Palm, et al.. (2017). Tenapanor administration and the activity of the H+‐coupled transporter PepT1 in healthy volunteers. British Journal of Clinical Pharmacology. 83(9). 2008–2014. 10 indexed citations
9.
Johansson, Susanne, Mikael Knutsson, Maria Leonsson‐Zachrisson, & David P. Rosenbaum. (2017). Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study. Clinical Pharmacology in Drug Development. 6(5). 457–465. 6 indexed citations
10.
Johansson, Susanne, Jessica Read, Stuart Oliver, et al.. (2014). Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine. Clinical Pharmacokinetics. 53(9). 837–847. 52 indexed citations
11.
Egstrup, Kenneth, Lennart Bergfeldt, Lars Gullestad, et al.. (2011). QT Response after a Test Dose and during Maintenance Therapy with AZD1305 in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. 11(3). 199–208. 1 indexed citations
12.
Toivonen, Lauri, Pekka Raatikainen, Håkan Walfridsson, et al.. (2010). A Randomized Invasive Cardiac Electrophysiology Study of the Combined Ion Channel Blocker AZD1305 in Patients After Catheter Ablation of Atrial Flutter. Journal of Cardiovascular Pharmacology. 56(3). 300–308. 6 indexed citations
13.
Lundh, Håkan, Ola Nilsson, I. Rosén, & Susanne Johansson. (2009). Practical aspects of 3,4-diaminopyridine treatment of the Lambert-Eaton myasthenic syndrome. Acta Neurologica Scandinavica. 88(2). 136–140. 23 indexed citations
14.
Asplund, Ragnar, Susanne Johansson, S. Henriksson, & Göran Isacsson. (2005). Nocturia, depression and antidepressant medication. British Journal of Urology. 95(6). 820–823. 38 indexed citations
15.
Johansson, Susanne, Marjo Apajasalo, Toni Sarapohja, & Chris Garratt. (2004). Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study. Critical Care. 8(Suppl 1). P88–P88. 10 indexed citations
16.
Asplund, Ragnar, S. Henriksson, Susanne Johansson, & Göran Isacsson. (2004). Nocturia and depression. British Journal of Urology. 93(9). 1253–1256. 67 indexed citations
17.
Niklasson, Bo, Knud Erik Heller, Mogens Bildsøe, et al.. (2003). Development of Type 1 Diabetes in Wild Bank Voles Associated With Islet Autoantibodies and the NovelLjungan Virus. Journal of Diabetes Research. 4(1). 35–44. 70 indexed citations
18.
Eriksson, Ulf G., Susanne Johansson, Per‐Ola Attman, et al.. (2003). Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran. Clinical Pharmacokinetics. 42(8). 743–753. 42 indexed citations
19.
Bredberg, Eva, Tommy B. Andersson, Lars Frison, et al.. (2003). Ximelagatran, an Oral Direct Thrombin Inhibitor, Has a Low Potential for Cytochrome P450-Mediated Drug-Drug Interactions. Clinical Pharmacokinetics. 42(8). 765–777. 83 indexed citations
20.
Lindberg, Anders, et al.. (1999). Echovirus 5: infectious transcripts and complete nucleotide sequence from uncloned cDNA. Virus Research. 59(1). 75–87. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nam Ho Kim Breakdown of academic impact, for papers by Gabriele Halwachs‐Baumann Breakdown of academic impact, for papers by İbrahim Aydın Breakdown of academic impact, for papers by Ellis Jacobs Breakdown of academic impact, for papers by Lei Hou Breakdown of academic impact, for papers by William D. Hoffman Breakdown of academic impact, for papers by Hua Ling Breakdown of academic impact, for papers by Eizo Watanabe Breakdown of academic impact, for papers by Céline Lange Breakdown of academic impact, for papers by Yu Cao
Rankless by CCL
2026